Overview

Phenylephrine Infusion in Cesarean Delivery

Status:
Unknown status

Trial end date:
2020-05-25

Target enrollment:

Participant gender:

Summary

the investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single shot (1.5 mcg/Kg) phenylephrine

Phase:

Phase 4

Details

Lead Sponsor:

Cairo University

Treatments:

Bupivacaine
Oxymetazoline
Phenylephrine